Items where Author is "Ellis, IO"

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Number of items: 51.

Journal article

RAKHA, E.A., ALESKANDARANI, M., TOSS, M.S., GREEN, A.R., BALL, G., ELLIS, I.O. and DALTON, L.W., 2018. Breast cancer histologic grading using digital microscopy: concordance and outcome association. Journal of Clinical Pathology. ISSN 0021-9746

MARTIN, S.G., LEBOT, M.N., SUKKARN, B., BALL, G., GREEN, A.R., RAKHA, E.A., ELLIS, I.O. and STORR, S.J., 2018. Low expression of G protein-coupled oestrogen receptor 1 (GPER) is associated with adverse survival of breast cancer patients. Oncotarget, 9 (40), pp. 25946-25956. ISSN 1949-2553

RAKHA, E.A., AGARWAL, D., GREEN, A.R., ASHANKYTY, I., ELLIS, I.O., BALL, G. and ALASKANDARANY, M.A., 2017. Prognostic stratification of oestrogen receptor-positive HER2-negative lymph node-negative class of breast cancer. Histopathology, 70 (4), pp. 622-631. ISSN 0309-0167

ARORA, A., PARVATHANENI, S., ALESKANDARANY, M.A., AGARWAL, D., ALI, R., ABDEL-FATAH, T., GREEN, A.R., BALL, G.R., RAKHA, E.A., ELLIS, I.O., SHARMA, S. and MADHUSUDAN, S., 2017. Clinicopathological and functional significance of RECQL1 helicase in sporadic breast cancers. Molecular Cancer Therapeutics, 16 (1), pp. 239-250. ISSN 1535-7163

ABDEL-FATAH, T.M.A., REES, R.C., POCKLEY, A.G., MOSELEY, P., BALL, G.R., CHAN, S.Y.T., ELLIS, I.O. and MILES, A.K., 2017. The localisation of pre mRNA splicing factor PRPF38B is a novel prognostic biomarker that may predict survival benefit of trastuzumab in patients with breast cancer overexpressing HER2. Oncotarget, 8, pp. 112245-112257. ISSN 1949-2553

ABDEL-FATAH, T.M.A., AGARWAL, D., LIU, D.X., RUSSELL, R., RUEDA, O.M., LIU, K., XU, B., MOSELEY, P.M., GREEN, A.R., POCKLEY, A.G., REES, R.C., CALDAS, C., ELLIS, I.O., BALL, G.R. and CHAN, S.Y.T., 2016. SPAG5 as a prognostic biomarker and chemotherapy sensitivity predictor in breast cancer: a retrospective, integrated genomic, transcriptomic, and protein analysis. The Lancet Oncology, 17 (7), pp. 1004-1018. ISSN 1470-2045

SHAMANNA, R.A., LU, H., CROTEAU, D.L., ARORA, A., AGARWAL, D., BALL, G., ALESKANDARANY, M.A., ELLIS, I.O., POMMIER, Y., MADHUSUDAN, S. and BOHR, V.A., 2016. Camptothecin targets WRN protein: mechanism and relevance in clinical breast cancer. Oncotarget, 7 (12). ISSN 1949-2553

ALESKANDARANY, M.A., AGARWAL, D., NEGM, O.H., BALL, G., ELMOUNA, A., ASHANKYTY, I., NUGLOZEH, E., FAZALUDEEN, M.F., DIEZ-RODRIGUEZ, M., NOLAN, C.C., TIGHE, P.J., GREEN, A.R., ELLIS, I.O. and RAKHA, E.A., 2016. The prognostic significance of STAT3 in invasive breast cancer: analysis of protein and mRNA expressions in large cohorts. Breast Cancer Research and Treatment, 156 (1), pp. 9-20. ISSN 0167-6806

GREEN, A.R., SORIA, D., STEPHENS, J., POWE, D.G., NOLAN, C.C., KUNKLER, I., THOMAS, J., KERR, G.R., JACK, W., CAMERON, D., PIPER, T., BALL, G.R., GARIBALDI, J.M., RAKHA, E.A., BARTLETT, J.M.S. and ELLIS, I.O., 2016. Nottingham Prognostic Index Plus: Validation of a clinical decision making tool in breast cancer in an independent series. The Journal of Pathology: Clinical Research, 2 (1), pp. 32-40. ISSN 2056-4538

ARORA, A., ABDEL-FATAH, T.M.A., AGARWAL, D., DOHERTY, R., CROTEAU, D.L., MOSELEY, P.M., HAMEED, K., GREEN, A., ALESKANDARANY, M.A., RAKHA, E.A., PATTERSON, K., BALL, G., CHAN, S.Y.T., ELLIS, I.O., BOHR, V.A., BRYANT, H.E. and MADHUSUDAN, S., 2016. Clinicopathological and prognostic significance of RECQL5 helicase expression in breast cancers. Carcinogenesis, 37 (1), pp. 63-71. ISSN 0143-3334

ABDEL-FATAH, T.M.A., MCARDLE, S.E., AGARWAL, D., MOSELEY, P.M., GREEN, A.R., BALL, G.R., POCKLEY, A.G., ELLIS, I.O., REES, R.C. and CHAN, S.Y.T., 2015. HAGE in triple negative breast cancer (TNBC) is a novel prognostic, predictive and actionable biomarker: a transcriptomic and protein expression analysis. Clinical Cancer Research. ISSN 1078-0432

ABDEL-FATAH, T.M., BALL, G., LEE, A.H.S., PINDER, S., MACMILAN, R.D., CORNFORD, E., MOSELEY, P.M., SILVERMAN, R., PRICE, J., LATHAM, B., PALMER, D., CHAN, A., ELLIS, I.O. and CHAN, S.Y.T., 2015. Nottingham Clinico-Pathological Response Index (NPRI) after Neoadjuvant Chemotherapy (Neo-ACT) Accurately Predicts Clinical Outcome in Locally Advanced Breast Cancer. Clinical Cancer Research, 21 (5), pp. 1052-1062. ISSN 1078-0432

ALBARAKATI, N., ABDEL-FATAH, T.M.A., DOHERTY, R., RUSSELL, R., AGARWAL, D., MOSELEY, P., PERRY, C., ARORA, A., ALSUBHI, N., SEEDHOUSE, C., RAKHA, E.A., GREEN, A., BALL, G., CHAN, S., CALDAS, C., ELLIS, I.O. and MADHUSUDAN, S., 2015. Targeting BRCA1-BER deficient breast cancer by ATM or DNA-PKcs blockade either alone or in combination with cisplatin for personalized therapy. Molecular Oncology, 9 (1), pp. 204-217. ISSN 1574-7891

ARORA, A., ABDEL-FATAH, T.M.A., AGARWAL, D., DOHERTY, R., MOSELEY, P.M., ALESKANDARANY, M.A., GREEN, A.R., BALL, G., ALSHAREEDA, A.T., RAKHA, E.A., CHAN, S.Y.T., ELLIS, I.O. and MADHUSUDAN, S., 2015. Transcriptomic and Protein Expression Analysis Reveals Clinicopathological Significance of Bloom Syndrome Helicase (BLM) in Breast Cancer. Molecular Cancer Therapeutics, 14 (4), pp. 1057-1065. ISSN 1535-7163

ABDEL-FATAH, T.M.A., MIDDLETON, F.K., ARORA, A., AGARWAL, D., CHEN, T., MOSELEY, P.M., PERRY, C., DOHERTY, R., CHAN, S., GREEN, A.R., RAKHA, E., BALL, G., ELLIS, I.O., CURTIN, N.J. and MADHUSUDAN, S., 2015. Untangling the ATR-CHEK1 network for prognostication, prediction and therapeutic target validation in breast cancer. Molecular Oncology, 9 (3), pp. 569-585. ISSN 1574-7891

POWE, D.G., DHONDALAY, G.K.R., LEMETRE, C., ALLEN, T., HABASHY, H.O., ELLIS, I.O., REES, R. and BALL, G., 2014. DACH1: its role as a classifier of long term good prognosis in luminal breast cancer. PLOS ONE, 9 (1). ISSN 1932-6203

ABDEL-FATAH, T., ARORA, A., AGARWAL, D., MOSELEY, P., PERRY, C., THOMPSON, N., GREEN, A.R., RAKHA, E., CHAN, S., BALL, G., ELLIS, I.O. and MADHUSUDAN, S., 2014. Adverse prognostic and predictive significance of low DNA-dependent protein kinase catalytic subunit (DNA-PKcs) expression in early-stage breast cancers. Breast Cancer Research and Treatment, 146 (2), pp. 309-320. ISSN 0167-6806

ABDEL-FATAH, T., ARORA, A., AGARWAL, D., MOSELEY, P., PERRY, C., THOMPSON, N., GREEN, A.R., RAKHA, E., CHAN, S., BALL, G., ELLIS, I.O. and MADHUSUDAN, S., 2014. Adverse prognostic and predictive significance of low DNA-dependent protein kinase catalytic subunit (DNA-PKcs) expression in early-stage breast cancers. Breast Cancer Research and Treatment, 146 (2), pp. 309-320. ISSN 0167-6806

ABDEL-FATAH, T.M.A., RUSSELL, R., AGARWAL, D., MOSELEY, P., ABAYOMI, M., PERRY, C., ALBARAKATI, N., BALL, G., CHAN, S., CALDAS, C., ELLIS, I.O. and MADHUSUDAN, S., 2014. DNA polymerase B deficiency is linked to aggressive breast cancer: a comprehensive analysis of gene copy number, mRNA and protein expression in multiple cohorts. Molecular Oncology, 8 (3), pp. 520-532. ISSN 1574-7891

ABDEL-FATAH, T.M.A., RUSSELL, R., ALBARAKATI, N., MALONEY, D.J., DORJSUREN, D., RUEDA, O.M., MOSELEY, P., MOHAN, V., SUN, H., ABBOTTS, R., MUKHERJEE, A., AGARWAL, D., ILLUZZI, J.L., JADHAV, A., SIMEONOV, A., BALL, G., CHAN, S., CALDAS, C., ELLIS, I.O., WILSON, D.M. and MADHUSUDAN, S., 2014. Genomic and protein expression analysis reveals flap endonuclease 1 (FEN1) as a key biomarker in breast and ovarian cancer. Molecular Oncology, 8 (7), pp. 1326-1338. ISSN 1574-7891

ABDEL-FATAH, T.M.A., MCARDLE, S.E.B., JOHNSON, C., MOSELEY, P.M., BALL, G.R., POCKLEY, A.G., ELLIS, I.O., REES, R.C. and CHAN, S.Y.T., 2014. HAGE (DDX43) is a biomarker for poor prognosis and a predictor of chemotherapy response in breast cancer. British Journal of Cancer, 110 (10), pp. 2450-2461. ISSN 1532-1827

ABDEL-FATAH, T.M.A., PERRY, C., DICKINSON, P., BALL, G., MOSELEY, P., MADHUSUDAN, S., ELLIS, I.O. and CHAN, S.Y.T., 2013. Bcl2 is an independent prognostic marker of triple negative breast cancer (TNBC) and predicts response to anthracycline combination (ATC) chemotherapy (CT) in adjuvant and neoadjuvant settings. Annals of Oncology, 24 (11), pp. 2801-2807. ISSN 1569-8041

ILYAS, M., GRABSCH, H., ELLIS, I.O., WOMACK, C., BROWN, R., BERNEY, D., FENNEL, D., SALTO-TELLEZ, M., JENKINS, M., LANDBERG, G., BYERS, R., TREANOR, D., HARRISON, D., GREEN, A.R., BALL, G. and HAMILTON, P., 2013. Guidelines and considerations for conducting experiments using tissue microarrays. Histopathology, 62 (6), pp. 827-839. ISSN 1365-2559

GREEN, A.R., POWE, D.G., RAKHA, E.A., SORIA, D., LEMETRE, C., NOLAN, C.C., BARROS, F.F.T., MACMILLAN, R.D., GARIBALDI, J.M., BALL, G.R. and ELLIS, I.O., 2013. Identification of key clinical phenotypes of breast cancer using a reduced panel of protein biomarkers. British Journal of Cancer, 109 (7), pp. 1886-1894. ISSN 0007-0920

LAVERSIN, S.A.-S., PHATAK, V.M., POWE, D.G., LI, G., MILES, A.K., HUGHES, D.C., BALL, G.R., ELLIS, I.O., GRITZAPIS, A.D., MISSITZIS, I., MCARDLE, S.E.B. and REES, R.C., 2013. Identification of novel breast cancer-associated transcripts by uniGene database mining and gene expression analysis in normal and malignant cells. Genes, Chromosomes and Cancer, 52 (3), pp. 316-329. ISSN 1098-2264

BAKER, B.G., BALL, G.R., RAKHA, E.A., NOLAN, C.C., CALDAS, C., ELLIS, I.O. and GREEN, A.R., 2013. Lack of expression of the proteins GMPR2 and PPARα are associated with the basal phenotype and patient outcome in breast cancer. Breast Cancer Research and Treatment, 137 (1), pp. 127-137. ISSN 0167-6806

ABDEL-FATAH, T.M.A., ALBARAKATI, N., BOWELL, L., AGARWAL, D., MOSELEY, P., HAWKES, C., BALL, G., CHAN, S., ELLIS, I.O. and MADHUSUDAN, S., 2013. Single-strand selective monofunctional uracil-DNA glycosylase (SMUG1) deficiency is linked to aggressive breast cancer and predicts response to adjuvant therapy. Breast Cancer Research and Treatment, 142 (3), pp. 515-527. ISSN 0167-6806

SULTANA, R., ABDEL-FATAH, T., ABBOTTS, R., HAWKES, C., ALBARAKATA, N., SEEDHOUSE, C., BALL, G., CHAN, S., RAKHA, E.A., ELLIS, I.O. and MADHUSUDAN, S., 2013. Targeting XRCC1 deficiency in breast cancer for personalized therapy. Cancer Research, 73 (5), pp. 1621-1634. ISSN 1538-7445

SORIA, D., GARIBALDI, J.M., GREEN, A.R., POWE, D.G., NOLAN, C.C., LEMETRE, C., BALL, G. and ELLIS, I.O., 2013. A quantifier-based fuzzy classification system for breast cancer patients. Artificial Intelligence in Medicine, 58 (3), pp. 175-184. ISSN 0933-3657

ALESKANDARANY, M.A., NEGM, O.H., RAKHA, E.A., AHMED, M.A.H., NOLAN, C.C., BALL, G.R., CALDAS, C., GREEN, A.R., TIGHE, P.J. and ELLIS, I.O., 2012. TOMM34 expression in early invasive breast cancer: a biomarker associated with poor outcome. Breast Cancer Research and Treatment, 136 (2), pp. 419-427. ISSN 0167-6806

STORR, S.J., MOHAMMED, R.A.A., WOOLSTON, C.M., GREEN, A.R., PARR, T., SPITERI, I., CALDAS, C., BALL, G.R., ELLIS, I.O. and MARTIN, S.G., 2011. Calpastatin is associated with lymphovascular invasion in breast cancer. The Breast, 20 (5), pp. 413-418. ISSN 0960-9776

ABDEL-FATAH, A., POWE, D.G., BALL, G., LOPEZ-GARCIA, M.A., HABASHY, H.O., GREEN, A.R., REIS-FILHO, J.S. and ELLIS, I.O., 2010. Proposal for a modified grading system based on mitotic index and Bcl2 provides objective determination of clinical outcome for patients with breast cancer. Journal of Pathology, 222 (4), pp. 388-399. ISSN 1096-9896

HABASHY, H.O., POWE, D.G., STAKA, C.M., RAKHA, E.A., BALL, G., GREEN, A.R., ALESKANDARANY, M., PAISH, E.C., MACMILLAN, R.D., NICHOLSON, R.I., ELLIS, I.O. and GEE, J.M.W., 2010. Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen. Breast Cancer Research and Treatment, 119 (2), pp. 283-293. ISSN 0167-6806

SORIA, D., GARIBALDI, J.M., AMBROGI, F., GREEN, A.R., POWE, D., RAKHA, E., MACMILLAN, R.D., BLAMEY, R.W., BALL, G., LISBOA, P.J.G., ETCHELLS, T.A., BORRACCH, P., BIGANZOLI, E. and ELLIS, I.O., 2010. A methodology to identify consensus classes from clustering algorithms applied to immunohistochemical data from breast cancer patients. Computers in Biology and Medicine, 40 (3), pp. 318-330. ISSN 1862-8346

HABASHY, H.O., POWE, D.G., RAKHA, E.A., BALL, G., MACMILLAN, R.D., GREEN, A.R. and ELLIS, I.O., 2010. The prognostic significance of PELP1 expression in invasive breast cancer with emphasis on the ER-positive luminal-like subtype. Breast Cancer Research and Treatment, 120 (3), pp. 603-612. ISSN 0167-6806

ZHANG, H., RAKHA, E.A., BALL, G.R., SPITERI, I., ALESKANDARANY, M., PAISH, E.C., POWE, D.G., MACMILLAN, R.D., CALDAS, C., ELLIS, I.O. and GREEN, A.R., 2010. The proteins FABP7 and OATP2 are associated with the basal phenotype and patient outcome in human breast cancer. Breast Cancer Research and Treatment, 121 (1), pp. 41-51. ISSN 0167-6806

LANCASHIRE, L.J., POWE, D.G., REIS-FILHO, J.S., RAKHA, E., LEMETRE, C., WEIGELT, B., ABDEL-FATAH, T.M., GREEN, A.R., MUKTA, R., BLAMEY, R., PAISH, E.C., REES, R.C., ELLIS, I.O. and BALL, G.R., 2010. A validated gene expression profile for detecting clinical outcome in breast cancer using artificial neural networks. Breast cancer research and treatment, 120 (1), pp. 83-93. ISSN 0167-6806

ELSHEIKH, S.E., GREEN, A.R., RAKHA, E.A., POWE, D.G., AHMED, R.A., COLLINS, H.M., SORIA, D., GARIBALDI, J.M., PAISH, C.E., AMMAR, A.A., GRAINGE, M.J., BALL, G.R., ABDELGHANY, M.K., MARTINEZ-POMARES, L., HEERY, D.M. and ELLIS, I.O., 2009. Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome. Cancer Research, 69 (9), pp. 3802-3809. ISSN 0008-5472

HABASHY, H.O., POWE, D.G., RAKHA, E.A., BALL, G., PAISH, C., GEE, J., NICHOLSON, R.I. and ELLIS, I.O., 2008. Forkhead-box A1 (FOXA1) expression in breast cancer and its prognostic significance. European Journal of Cancer, 44 (11), pp. 1541-1551. ISSN 0959-8049

MURALI-GANESH, R., POWE, D.G., PANCHOLI, A., BALL, G.R., RAKHA, E. and ELLIS, I.O., 2007. ALCAM is an independent predictor of survival in unselected breast cancer. Ejc Supplements, 5 (3), pp. 28-29. ISSN 1359-6349

MITCHELL, M.J., WISHART, G., BLAMEY, R.W., BALL, G.R. and ELLIS, I.O., 2007. Absolute gain. Ejc Supplements, 5 (3), p. 35. ISSN 1359-6349

GREEN, A.R., GARIBALDI, J.M., SORIA, D., AMBROGI, F., BALL, G., LISBOA, P.J.G., ETCHELLS, T.A., BORACCHI, P., BIGANZOLI, E., MACMILLAN, R.D., BLAMEY, R.W. and ELLIS, I.O., 2007. Identification of sub-classes of breast cancer through consensus derived from automated clustering methods. Ejc Supplements, 5 (3), p. 18. ISSN 1359-6349

BLAMEY, R.W., MITCHELL, M.J., BALL, G.R., GREEN, A., RAMPAUL, R., PINDER, S., LEE, A., MACMILLAN, R.D. and ELLIS, I.O., 2007. Prognostic estimation: re-analysis of data from cases diagnosed in 1990-99 by Cox proportional hazards method. Ejc Supplements, 5 (3), p. 28. ISSN 1359-6349

BLAMEY, R.W., PINDER, S.E., BALL, G.R., ELLIS, I.O., ELSTON, C.W., MITCHELL, M.J. and HAYBITTLE, J.L., 2007. Reading the prognosis of the individual with breast cancer. European Journal of Cancer, 43 (10), pp. 1545-1547. ISSN 0959-8049

BLAMEY, R.W., ELLIS, I.O., PINDER, S.E., LEE, A.H.S., MACMILLAN, R.D., MORGAN, D.A.L., ROBERTSON, J.F.R., MITCHELL, M.J., BALL, G.R., HAYBITTLE, J.L. and ELSTON, C.W., 2007. Survival of invasive breast cancer according to the Nottingham Prognostic Index in cases diagnosed in 1990-1999. European Journal of Cancer, 43 (10), pp. 1548-1555. ISSN 0959-8049

RAMPAUL, R.S., MITCHELL, M.J., PINDER, S.E., PAISH, C.E., BLAMEY, R.W., BD, E.R., BALL, G., ROBERTSON, J.F. and ELLIS, I.O., 2007. The effect of HER-2 overexpression on survival in early breast cancer. Ejc Supplements, 5 (3), pp. 27-28. ISSN 1359-6349

RAMPAUL, R.S., BALL, G., PAISH, C., PINDER, S.E., MITCHELL, M.J., BLAMEY, R.W., ROBERTSON, J.F.R., NICHOLSON, R.I., GEE, J.M., GULLICK, W.J. and ELLIS, I.O., 2007. erbB Signalling in breast cancer. Ejc Supplements, 5 (3), p. 32. ISSN 1359-6349

THOMPSON, N., LEIGH-BRAMWELL, S., POWE, D.G., BALL, G., RAKHA, E., WILLIAMS, J., PAISH, E.C. and ELLIS, I.O., 2006. Breast cancer profiling: A minimised panel of predictive markers for survival. Journal of Pathology, 210, p. 59. ISSN 0022-3417

BD, E.R., BALL, G., PINDER, S.E., RAKHA, E., PAISH, C., ROBERTSON, J.F.R., MACMILLAN, D., BLAMEY, R.W. and ELLIS, I.O., 2005. High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses. International Journal of Cancer, 116 (3), pp. 340-350. ISSN 0020-7136

EL-REHIM, D.M.A., BALL, G., PINDER, S. and ELLIS, I.O., 2004. Molecular classification of breast carcinoma based on the protein expression immunoprofiles. Journal of Pathology, 204. ISSN 0022-3417

BALL, G., MIAN, S., HOLDING, F., ALLIBONE, R.O., LOWE, J., ALI, S., LI, G., MCCARDLE, S., ELLIS, I.O., CREASER, C. and REES, R.C., 2002. An integrated approach utilizing artificial neural networks and SELDI mass spectrometry for the classification of human tumours and rapid identification of potential biomarkers. Bioinformatics, 18 (3), pp. 395-404. ISSN 1367-4803

This list was generated on Thu Dec 5 22:42:33 2019 UTC.